Daniel Hétu

  • With 20 years of investment banking, corporate and business development, and licensing experience, Daniel has been involved with life science companies at all stages of development in North America and overseas.

    Before joining Lumira Capital in 2005, Daniel located in Montréal, spent 10 years at Shire Pharmaceuticals and at Biochem Pharma prior to its acquisition by Shire as vice president, business development North America (Shire), and vice president, corporate development (Biochem Pharma). During that period, he was involved with the in-licensing of a wide range of products and technologies as well as several financing and M&A transactions in the therapeutics, vaccine and diagnostics sectors. At Biochem, Daniel served on the Company’s portfolio committee and the steering committee of strategic research collaborations.

    Prior to joining Biochem Pharma, Daniel was an investment banker at a major Canadian investment bank where he was involved in M&A and financing transactions across various industrial sectors.

    Daniel holds an MD from Université de Sherbrooke, Québec, and an MBA from École des Hautes Études Commerciales (Montréal, Québec).

    This post is also available in: French